This site is intended only for healthcare professionals resident in the Republic of Ireland
Menu
Close
Patients treated with Enbrel should be given the Patient Card.
The recommended dose of Enbrel for JIA patients is weight-based:1
Discontinuation of treatment should be considered in JIA patients who show no response after 4 months. The 10 mg vial strength may be more appropriate for children below the weight of 25 kg1
Learn more about the efficacy and safety of Enbrel in JIA
Please refer to the ENBREL Summary of Product Characteristics for full prescribing information
Pfizer has resources available to support you and your Enbrel patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
I accept and agree to the terms of use.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023